Pharmacological characterization of Lu 25-109-T, a compound with M 1 -agonistic and M 2 /M 3 -antagonistic effects on muscarinic receptors.
Eddi Meier, John Hyttel, Hanne Løve Lembøl(Lundbeck (Denmark)), Henrik Pedersen(Lundbeck (Denmark)), C.F. Sánchez(Lundbeck (Denmark)), J. Arnt(Lundbeck (Denmark)), Torben Skarsfeldt(Lundbeck (Denmark)), Kristen Frederiksen(Mayo Clinic in Florida), Nils Dragsted(Lundbeck (Denmark))
Life Sciences
January 1, 1995
Cited by 2
Related Papers
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
|Journal of Medicinal Chemistry|2011|602
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
|Journal of Neuroscience|1988|560
Immortalization of precursor cells from the mammalian CNS
|Neuron|1988|326
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
|Journal of Neurochemistry|1990|228
NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization
|European Journal of Pharmacology|1992|160